Clinical Trials Browser

Active not recruiting × INDUSTRY × aumolertinib × Clear all

NCT04923906 2024-11-25

Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04687241 2024-11-07

Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung